175 related articles for article (PubMed ID: 26935240)
1. Suppressive effect of topoisomerase inhibitors on JC polyomavirus propagation in human neuroblastoma cells.
Nukuzuma S; Nakamichi K; Kameoka M; Sugiura S; Nukuzuma C; Tasaki T; Takegami T
Microbiol Immunol; 2016 Apr; 60(4):253-60. PubMed ID: 26935240
[TBL] [Abstract][Full Text] [Related]
2. CPT11 prevents virus replication in JCI cells persistently infected with JC polyomavirus.
Nukuzuma S; Nukuzuma C; Kameoka M; Sugiura S; Nakamichi K; Tasaki T; Takegami T
Microbiol Immunol; 2017 Jun; 61(6):232-238. PubMed ID: 28463406
[TBL] [Abstract][Full Text] [Related]
3. Human iPS cell-derived astrocytes support efficient replication of progressive multifocal leukoencephalopathy-type JC polyomavirus.
Shimbo E; Nukuzuma S; Tagawa YI
Biochem Biophys Res Commun; 2020 Dec; 533(4):983-987. PubMed ID: 33008586
[TBL] [Abstract][Full Text] [Related]
4. Establishment of COS-JC cells persistently producing archetype JC polyomavirus.
Nukuzuma S; Nukuzuma C; Kameoka M; Sugiura S; Nakamichi K; Tasaki T; Hidaka K; Takegami T
Microbiol Immunol; 2018 Aug; 62(8):524-530. PubMed ID: 29932215
[TBL] [Abstract][Full Text] [Related]
5. Antiviral effects of artesunate on JC polyomavirus replication in COS-7 cells.
Sharma BN; Marschall M; Rinaldo CH
Antimicrob Agents Chemother; 2014 Nov; 58(11):6724-34. PubMed ID: 25155602
[TBL] [Abstract][Full Text] [Related]
6. Characterization of JC Polyomavirus Derived from COS-IMRb Cells.
Nukuzuma S; Nukuzuma C; Kameoka M; Sugiura S; Nakamichi K; Tasaki T; Hidaka K; Takegami T
Jpn J Infect Dis; 2021 Jan; 74(1):48-53. PubMed ID: 32741932
[TBL] [Abstract][Full Text] [Related]
7. Progressive multifocal leukoencephalopathy-associated mutations in the JC polyomavirus capsid disrupt lactoseries tetrasaccharide c binding.
Maginnis MS; Ströh LJ; Gee GV; O'Hara BA; Derdowski A; Stehle T; Atwood WJ
mBio; 2013 Jun; 4(3):e00247-13. PubMed ID: 23760462
[TBL] [Abstract][Full Text] [Related]
8. High expression of JC polyomavirus-encoded microRNAs in progressive multifocal leukoencephalopathy tissues and its repressive role in virus replication.
Takahashi K; Sato Y; Sekizuka T; Kuroda M; Suzuki T; Hasegawa H; Katano H
PLoS Pathog; 2020 Apr; 16(4):e1008523. PubMed ID: 32324824
[TBL] [Abstract][Full Text] [Related]
9. JC Polyomavirus Infection Reveals Delayed Progression of the Infectious Cycle in Normal Human Astrocytes.
Wilczek MP; DuShane JK; Armstrong FJ; Maginnis MS
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826993
[TBL] [Abstract][Full Text] [Related]
10. ERK Is a Critical Regulator of JC Polyomavirus Infection.
DuShane JK; Wilczek MP; Mayberry CL; Maginnis MS
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321332
[TBL] [Abstract][Full Text] [Related]
11. High-throughput drug screen identifies calcium and calmodulin inhibitors that reduce JCPyV infection.
Bond ACS; Crocker MA; Wilczek MP; DuShane JK; Sandberg AL; Bennett LJ; Leclerc NR; Maginnis MS
Antiviral Res; 2024 Feb; 222():105817. PubMed ID: 38246207
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of JCPyV infection mediated by targeted viral genome editing using CRISPR/Cas9.
Chou YY; Krupp A; Kaynor C; Gaudin R; Ma M; Cahir-McFarland E; Kirchhausen T
Sci Rep; 2016 Nov; 6():36921. PubMed ID: 27841295
[TBL] [Abstract][Full Text] [Related]
13. Comparison of qPCR with ddPCR for the Quantification of JC Polyomavirus in CSF from Patients with Progressive Multifocal Leukoencephalopathy.
Ngouth N; Monaco MC; Walker L; Corey S; Ikpeama I; Fahle G; Cortese I; Das S; Jacobson S
Viruses; 2022 Jun; 14(6):. PubMed ID: 35746716
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of serotonin antagonists on JC virus propagation in a carrier culture of human neuroblastoma cells.
Nukuzuma S; Nakamichi K; Nukuzuma C; Takegami T
Microbiol Immunol; 2009 Sep; 53(9):496-501. PubMed ID: 19703243
[TBL] [Abstract][Full Text] [Related]
15. Archetype JC polyomavirus DNA associated with extracellular vesicles circulates in human plasma samples.
Scribano S; Guerrini M; Arvia R; Guasti D; Nardini P; Romagnoli P; Giannecchini S
J Clin Virol; 2020 Jul; 128():104435. PubMed ID: 32442760
[TBL] [Abstract][Full Text] [Related]
16. Detection and analysis of variants of JC polyomavirus in urine samples from HIV-1-infected patients in China's Zhejiang Province.
Hu C; Huang Y; Su J; Wang M; Zhou Q; Zhu B
J Int Med Res; 2018 Mar; 46(3):1024-1032. PubMed ID: 29322824
[TBL] [Abstract][Full Text] [Related]
17. IFNα and β Mediated JCPyV Suppression through C/EBPβ-LIP Isoform.
May D; Bellizzi A; Kassa W; Cipriaso JM; Caocci M; Wollebo HS
Viruses; 2021 Sep; 13(10):. PubMed ID: 34696366
[TBL] [Abstract][Full Text] [Related]
18. JC Polyomavirus Entry by Clathrin-Mediated Endocytosis Is Driven by β-Arrestin.
Mayberry CL; Soucy AN; Lajoie CR; DuShane JK; Maginnis MS
J Virol; 2019 Apr; 93(8):. PubMed ID: 30700597
[TBL] [Abstract][Full Text] [Related]
19. The human JC polyomavirus (JCPyV): virological background and clinical implications.
Hirsch HH; Kardas P; Kranz D; Leboeuf C
APMIS; 2013 Aug; 121(8):685-727. PubMed ID: 23781977
[TBL] [Abstract][Full Text] [Related]
20. Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.
Jelcic I; Combaluzier B; Jelcic I; Faigle W; Senn L; Reinhart BJ; Ströh L; Nitsch RM; Stehle T; Sospedra M; Grimm J; Martin R
Sci Transl Med; 2015 Sep; 7(306):306ra150. PubMed ID: 26400911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]